degradation to prevent the synthesis of truncated proteins. NMD also regulates the steady-state level of a wide range of physiological substrates [2] .
Work over the years has provided significant insights into the molecular mechanisms of aberrant mRNA detection in the NMD pathway [1, [3] [4] [5] [6] [7] . NMD requires translating ribosomes and a signal downstream of the stop codon to define the context of translation termination as physiological or aberrant. The mechanistic details and specificities in each organism are a matter of debate and intense research [8] [9] [10] [11] [12] [13] [14] [15] [16] . In humans, the exon-junction-complex (EJC), four proteins assembled onto mRNA at a few nucleotides upstream of the exon-exon boundary upon splicing, is a major downstream element promoting NMD (Figure 1a) . NMD is elicited when termination of translation occurs prematurely at least 50-55 nucleotides upstream of a 3' exon-exon junction [1, 3] . Despite intensive research, we do not fully understanding the molecular basis of this 50-55 nucleotide rule. According to current models, a large complex bridging the ribosome and an EJC, and containing the three UP-Frameshift proteins, UPF1, UPF2 and UPF3, assembles only when a downstream EJC comes into proximity of a ribosome that has terminated prematurely ( Figure 1a ) [1, [3] [4] [5] [6] [7] 17] . UPF1 is an RNA helicase that associates with ribosomes by interacting with eukaryotic release factors (eRFs) eRF1 and eRF3. UPF1 can interact also with UPF2. UPF2 can bind UPF3, which is anchored to the EJC. UPF3 is found as two homologous proteins UPF3a and UPF3b in human cells. Upon formation of this large complex, SMG1 (Suppressor with Morphogenetic effect on Genitalia 1), a  430 kDa serine-threonin kinase belonging to the phosphatidylinositol 3-kinase-related protein kinase (PIKK) family [18] , phosphorylates UPF1 [19] . Phospho-UPF1 determines the fate of the mRNA towards degradation [20] .
A molecular view of NMD regulation provided by EM
Despite recent advances in the field, our understanding of the molecular basis of NMD is incomplete by the lack of a detailed structural view of the multiple interactions regulating this pathway. Most of our structural knowledge has been obtained by X-ray crystallography of UPF proteins and partial complexes (Figure 1) (Figure 1b) , which were compared with the structure UPF1 bound to the C-terminal domain of UPF2 solved by Cusack and colleagues (Max Planck Institute, Grenoble) [23] (Figure 1c) .
These structures revealed that a large conformational change relocates the cysteinehistidine-rich (CH) domain of UPF1, and the helicase activity is activated. UPF2
interacts with an N-terminal region of UPF3 and the structure of a complex containing the interacting domains of each protein has also been solved [27] (Figure 1d) . A Cterminal peptide of UPF3 is sufficient to provide the link between UPF3 and the EJC as revealed by the structure of a UPF3 fragment bound to the EJC [24] (Figure 1e) . 
EM combined with functional assays reveals SMG1 kinase regulation by SMG8
SMG1 triggers NMD by phosphorylating the UPF1 helicase, but little is known about the mechanisms by which this kinase activity is confined to the context of an aberrant mRNA [29] . In 2009, Shigeo Ohno, Akio Yamashita and colleagues at Yokohama University described two proteins, SMG8 and SMG9, that co-purified with SMG1 and which were essential for NMD [30] . In collaboration with Ohno and Yamashita, we have described the overall architecture of SMG1 and the modulation of its kinase activity by the interaction with SMG8 and SMG9 [31,32] . SMG1 comprises several conserved domains at the C-terminus, including the catalytic PI3K kinase domain, and a long stretch of multiple helical repeats, mostly HEAT (huntingtin, elongation factor 3, A subunit of PP2A and TOR1) repeats, organized as super-helical structures at the Nterminus [19] . SMG1 and the SMG1-SMG9 complex appeared in EM as "question mark" shaped-molecules with a large "head" region and a protruding "arm" (Figure   2a ). SMG1 C-terminal end was located at the "head" region, which showed similarities with the C-terminus of DNA-PKcs (DNA-dependent Protein Kinase catalytic subunit), a member of the PIKK family that has been extensively characterized [33] . SMG1 Nterminal end was arranged as an "arm" extending from the catalytic C-terminus. A combination of EM, mapping experiments and functional assays revealed that this helical N-terminal domain interacted with SMG9, which in turn recruited SMG8 [32].
SMG8 was identified by comparing images of SMG1-SMG8-SMG9 and SMG1-SMG9
( Figure 2b) [32]. Therefore, SMG1 helical region functions as a scaffold for the assembly of a larger complex, a property described for other PIKKs [33] as well as other proteins containing HEAT repeats [34, 35] . Interestingly, SMG8 binding downregulated SMG1 despite interacting far from the kinase domain. Large-scale conformational changes were observed in the N-and C-terminal regions of SMG1-SMG9 after SMG8 recruitment, which we propose down-regulate the kinase ( Figure   2c ). This model is consistent with the complex regulation of PI3-kinases [18] and the large conformational changes described for HEAT repeats proteins interacting with other proteins [34, 35] .
These results provide some insights into SMG1 regulation but new questions arise.
What steps remove SMG8 inhibition to facilitate UPF1 phosphorylation? SMG1 activation could be achieved by disrupting the SMG1-SMG8-SMG9 complex and/or additional conformational changes induced by other factors or proteins binding to SMG1. The answer maybe found by elucidating how this inhibitory mechanism is coordinated with the rest of events that take place during recognition of an aberrant mRNA. UPF2 binds a C-terminal fragment of SMG1, adding a potential new level of regulation [36] .
Architecture of the UPF-EJC complex resolved by cryoEM
A recent study has provided a pseudo-atomic model of a complex containing UPF1, UPF2, UPF3 and EJC (UPF-EJC hereafter) by combining a cryoEM structure of the complex with partial crystal structures, and integrating positional restrains obtained by labeling experiments of the components [37] (Figure 3a) . UPF-EJC was reconstituted from the individual components by Elena Conti and colleagues (Max Planck Institute, Martinsried) and analyzed by our group using EM. Interestingly, UPF-EJC was only stable at high concentrations, whereas it disassembled at the concentrations required for EM analysis. Therefore, the complex was stabilized with a mild fixation coupled to purification in a sucrose gradient using the GraFix method [38] . We determined the 3D structure of this 390 kDa complex at ~16 Å resolution using cryoEM. The positions of the individual components were mapped by antibody labeling, the structural characterization of several sub-complexes (UPF1-UPF2-UPF3-EJC, UPF2-UPF3-EJC, UPF1-UPF2-UPF3, UPF2-UPF3 and UPF2) by EM and the fitting of available crystal structures and homology models. UPF1 is part of SURF (SMG1-UPF1-Release-Factors), a probably transient NMD complex assembled at the ribosome that contains SMG1, UPF1 and release factors eRF1 and eRF3 [36] . UPF1 would be expected to locate at the 5'end of the EJC bound RNA as part of SURF (Figure 1a) . We assessed whether UPF1 was placed towards the 5' or the 3' end of the EJC by reconstituting UPF-EJC with an EJC bound to RNAs labeled with streptavidin at each end. Mechanistically, this allowed addressing that UPF1 was positioned towards the substrate of its helicase activity (the RNA 3' end) in the context of UPF-EJC rather than towards the ribosome (Figure 3b) . Remarkably, recent findings have revealed that UPF1 ATPase activity in the 5' to 3' direction is essential to strip proteins and dismantle the downstream mRNP during NMD [39] . This suggested that cryoEM had trapped a transient NMD complex at a stage when UPF1 is ready to function as a helicase towards the 3' end of the mRNP. How is UPF1 that is initially in complex with SMG1 and the ribosome as part of SURF relocated to the RNA 3' end at a later stage of the NMD reaction? This transition might be part of the dynamics connecting early and late events during recognition of aberrant mRNAs with short-lived transient complexes regulating SMG1 activation and UPF1 phosphorylation.
EM and mass spectrometry show that UPF2 is an open ring-like scaffold coordinating the assembly of the surveillance complex
The UPF-EJC structure revealed that the crosstalk between UPF1, UPF2 UPF3 and the EJC involves a set of interactions with UPF2 as a core scaffold as well as multiple 
Conclusions and outlook
The crosstalk between the stalled ribosome and the EJC involves a number of SMG/UPF proteins that interact, either sequentially or concomitantly, ensuing mRNA degradation. NMD factors interact forming several complexes containing different subunits and conformations. Many of these interactions will be labile and short-lived.
Recent EM studies integrating structures resolved by X-ray crystallography and information provided by labeling experiments, functional assays and mass spectrometry have provided important insights into the complexity of NMD [32, 37]. UPF1 binds to the ribosome as part of a complex with released factors and SMG1 (SURF) when the ribsosome encounters a stop codon (Figure 1a) . SMG1 kinase activity is down regulated by SMG8 and SMG9 (Figure 2) . Only when translation termination is premature, interactions linking SURF components to a downstream EJC can be established. As part of this large complex, UPF2 forms an open ring that interacts with UPF1 and induces an active conformation of this RNA helicase, whereas UPF3 brings UPF2 to the EJC (Figure 3) . At some stage, SMG1 phosphorylates UPF1, which transits from the SURF complex to the 3' side of the EJC, poised to strip proteins at the 3' end of the mRNP (Figure 3 [1, [3] [4] [5] [6] [7] . SMG1, UPF1 and release factors eRF1 and eRF3 interact to form the SURF complex in association with the ribosome [36] . A molecular link between SURF components and a downstream EJC is required to trigger UPF1 phosphorylation by the SMG1 kinase (indicated as an arrow). UPF2 and UPF3 required to bridge UPF1 and the EJC [17] . SMG1 kinase is regulated by SMG8 and SMG9 [30] , but interactions of SMG1 and UPF2 have also been described [36] . Structural insights into the mechanism for detecting PTCs in the NMD pathway have been obtained mostly by X-ray crystallography studies. The crystal structures of the UPF1 helicase (yellow color) in The two RecA domains of UPF1 helicase region have been labeled. A complex comprising interacting fragments of UPF2 (blue color) and UPF3b (yellow color) [27] (d), as well as a complex between a small UPF3b peptide (green color) sufficient to recognize the EJC complex (orange and red colors) [24] (e) have also been solved. [24] , of UPF1 bound to the C-terminal domain of UPF2 (PDB 2WJV) [23] , of the C-terminal MIF4G 3 domain of UPF2 bound to an Nterminal fragment of UPF3 (PDB 1UW4) [27] and homology models for MIF4G 1 showing that UPF1 ATPase activity is required to remodel the 3' end of the mRNP [39] .
Color codes: UPF1 (yellow), UPF2 (blue), UPF3 (green), EJC (orange and red), RNA in EJC (black).
